A detailed history of Citigroup Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Citigroup Inc holds 114,641 shares of GH stock, worth $3.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
114,641
Previous 31,276 266.55%
Holding current value
$3.74 Million
Previous $903,000 191.03%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$22.3 - $36.29 $1.86 Million - $3.03 Million
83,365 Added 266.55%
114,641 $2.63 Million
Q2 2024

Aug 12, 2024

SELL
$16.07 - $31.84 $118,387 - $234,565
-7,367 Reduced 19.06%
31,276 $903,000
Q1 2024

May 10, 2024

BUY
$17.13 - $26.91 $98,137 - $154,167
5,729 Added 17.41%
38,643 $797,000
Q4 2023

Feb 09, 2024

BUY
$21.58 - $29.5 $351,948 - $481,115
16,309 Added 98.22%
32,914 $890,000
Q3 2023

Nov 09, 2023

SELL
$25.8 - $39.97 $1.05 Million - $1.63 Million
-40,701 Reduced 71.02%
16,605 $492,000
Q2 2023

Aug 10, 2023

SELL
$20.94 - $38.01 $936,248 - $1.7 Million
-44,711 Reduced 43.83%
57,306 $2.05 Million
Q1 2023

May 11, 2023

BUY
$22.92 - $33.76 $1.94 Million - $2.85 Million
84,481 Added 481.76%
102,017 $2.39 Million
Q4 2022

Feb 09, 2023

SELL
$25.44 - $59.78 $257,223 - $604,435
-10,111 Reduced 36.57%
17,536 $476,000
Q3 2022

Nov 10, 2022

SELL
$43.66 - $61.0 $147,832 - $206,546
-3,386 Reduced 10.91%
27,647 $1.49 Million
Q2 2022

Aug 10, 2022

SELL
$28.82 - $77.35 $106,720 - $286,427
-3,703 Reduced 10.66%
31,033 $1.25 Million
Q1 2022

May 12, 2022

SELL
$48.25 - $100.49 $1.93 Million - $4.01 Million
-39,913 Reduced 53.47%
34,736 $2.3 Million
Q4 2021

Feb 10, 2022

BUY
$88.71 - $120.43 $3.42 Million - $4.64 Million
38,543 Added 106.75%
74,649 $7.47 Million
Q3 2021

Nov 10, 2021

BUY
$98.77 - $132.17 $3.57 Million - $4.77 Million
36,106 New
36,106 $4.51 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.34B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.